Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proof of efficacy trials: endpoints.

J A French1

  • 1The Neurological Institute, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. frenchj@mail.upenn.edu

Epilepsy Research
|July 20, 2001
PubMed
Summary

Seizure frequency data present analytical challenges due to variability and non-parametric nature. Researchers commonly use data manipulations and alternative endpoints in epilepsy clinical trials to improve analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex differences in vocal structure in a callitrichid primate, Leontopithecus rosalia.

American journal of primatology·2020
Same author

Evidence-Based Guideline: Management of an Unprovoked First Seizure in Adults: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Epilepsy currents·2015
Same author

Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR™) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial.

Acta neurologica Scandinavica·2013
Same author

Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.

Neurology·2012
Same author

Minimal mortality benefit with early surgery for high-risk fractured hip patients.

British journal of anaesthesia·2011
Same author

Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.

Neurology·2011

Area of Science:

  • Neurology
  • Clinical Trials
  • Biostatistics

Background:

  • Seizure frequency data exhibit high variability, both between and within patients.
  • Seizure clustering further complicates the analysis of seizure frequency.
  • Non-parametric nature of seizure data necessitates data transformation for certain statistical methods.

Purpose of the Study:

  • To discuss the challenges in analyzing seizure frequency data in clinical trials.
  • To highlight common data manipulations and alternative endpoints used in epilepsy research.
  • To emphasize the importance of endpoint selection based on study design.

Main Methods:

  • Review of common practices in analyzing seizure frequency data.
  • Discussion of data transformations and derived endpoints.
  • Exploration of alternative outcome measures in epilepsy studies.

Main Results:

  • Data manipulations like responder proportions and response ratios are frequently employed.
  • Alternative endpoints such as time to nth seizure and seizure-free days offer valuable insights.
  • Seizure severity scales provide additional quantitative measures.

Conclusions:

  • Standard seizure frequency analysis is challenging due to data characteristics.
  • Modified endpoints and data manipulations enhance the analysis of seizure data in clinical trials.
  • Endpoint choice is critical and must align with the specific study design.

Related Experiment Videos